Schedule 13G ownership disclosure
ADLAI NORTYE LTD
Ordinary shares, par value US$0.0001 per share · CUSIP: 00704R109
Event date: 2023-10-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Boary Investment Co. Ltd.
Shares: 5,304,468.00 · Class: 4.79%
- Suzhou Baoruiheng Venture Capital Partnership
Shares: 5,304,468.00 · Class: 4.79%
- Xiamen Biotime Biotechnology Co., Ltd.
Shares: 5,304,468.00 · Class: 4.79%
- Xiamen Baotai Holding Group Co., Ltd.
Shares: 5,304,468.00 · Class: 4.79%
- Xiamen WangChen Health Industry Co., Ltd.
Shares: 5,304,468.00 · Class: 4.79%
- Zhang Guofeng
Shares: 5,304,468.00 · Class: 4.79%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-037032
- Form type
- SCHEDULE 13G
- Filer
- Adlai Nortye Ltd.
- CIK
- CIK 1944552
- Filed
- Apr 29, 2025
- Reporting period
- Oct 03, 2023
- Description
- Schedule 13G beneficial ownership